Search IPOs
Subscription Status · May 21 – May 25, 2026 · ₹132–139
The Bio Medica Laboratories IPO subscription has recorded healthy investor demand with an overall subscription of 2.31× as of May 25, 2026, indicating that investors applied for 2.31 times the number of shares on offer. All investor categories (institutional, HNI, and retail) have participated actively, making this one of the closely watched IPO openings.
Last updated: May 25, 2026, 6:22 PM IST
| Category | Shares Offered | Shares Bid For | Times Subscribed | Applications |
|---|---|---|---|---|
|
QIB
Qualified Institutional Buyers
|
36,000 | 574,000 |
15.94×
|
6 |
|
NII
Non-Institutional Investors
|
1,755,000 | 2,475,000 |
1.41×
|
457 |
|
bNII
Bids above ₹10L
|
1,170,000 | 1,193,000 |
1.02×
|
35 |
|
sNII
Bids below ₹10L
|
585,000 | 1,282,000 |
2.19×
|
422 |
|
Individual
Individual Investors
|
1,792,000 | 5,228,000 |
2.92×
|
2,614 |
|
Total
|
3,583,000 | 8,277,000 |
2.31×
|
3,534 |
How subscription built up across investor categories over time
Snapshot of each day's bidding activity
| Category | Offered | Bid For | Times | Applications |
|---|---|---|---|---|
| QIB | 36,000 | 574,000 | 15.94× | 6 |
| NII | 1,755,000 | 52,000 | 0.03× | 13 |
| bNII | 1,170,000 | 16,000 | 0.01× | 2 |
| sNII | 585,000 | 36,000 | 0.06× | 11 |
| Individual Investors | 1,792,000 | 1,956,000 | 1.09× | 978 |
| Total | 3,583,000 | 2,582,000 | 0.72× | 1,010 |
| Category | Offered | Bid For | Times | Applications |
|---|---|---|---|---|
| QIB | 36,000 | 574,000 | 15.94× | 6 |
| NII | 1,755,000 | 674,000 | 0.38× | 98 |
| bNII | 1,170,000 | 407,000 | 0.35× | 12 |
| sNII | 585,000 | 267,000 | 0.46× | 86 |
| Individual Investors | 1,792,000 | 2,540,000 | 1.42× | 1,270 |
| Total | 3,583,000 | 3,788,000 | 1.06× | 1,472 |
| Category | Offered | Bid For | Times | Applications |
|---|---|---|---|---|
| QIB | 36,000 | 574,000 | 15.94× | 6 |
| NII | 1,755,000 | 2,475,000 | 1.41× | 457 |
| bNII | 1,170,000 | 1,193,000 | 1.02× | 35 |
| sNII | 585,000 | 1,282,000 | 2.19× | 422 |
| Individual Investors | 1,792,000 | 5,228,000 | 2.92× | 2,614 |
| Total | 3,583,000 | 8,277,000 | 2.31× | 3,534 |
As of May 25, 2026, the Bio Medica Laboratories IPO has been subscribed 2.31 times overall. The IPO is fully subscribed. A total of 3,534 applications received across all categories.
The Bio Medica Laboratories IPO subscription window was open from May 21, 2026 to May 25, 2026. Investors could apply through their demat account or ASBA facility.
The Bio Medica Laboratories IPO has a price band of ₹132 to ₹139 per share, with a lot size of 1,000 shares. Minimum retail investment: ₹132,000 (lower band) or ₹139,000 (upper band).
The QIB category has been subscribed 15.94 times. QIBs were offered 36,000 shares. Strong QIB subscription indicates high institutional confidence.
Overall NII: 1.41×. bNII (>₹10L): 1.02×, sNII (<₹10L): 2.19×. NII includes HNIs and corporate entities investing above ₹2 lakh.
Basis of allotment is on May 26, 2026. Check via the registrar's website, Skyline Financial Services Pvt.Ltd. using your PAN number, application number, or DP/Client ID. You can also check on BSE/NSE websites or through your broker's app.
Bio Medica Laboratories IPO is expected to list on May 29, 2026. Shares will list on NSE SME platform. Allotted shares are credited to your demat account 1 business day before listing.
A subscription multiple of 2.31× means investors have bid for 2.31 times the total shares available. Since the IPO is oversubscribed, not every applicant will receive shares, allotment happens via lottery (for retail) or proportionately (for other categories). Higher multiples generally reduce allotment probability.
Based on the current retail subscription of data pending, the estimated allotment probability for retail investors is Moderate. Better odds than heavily subscribed IPOs. If final subscription stays below 1×, all applicants are likely to get full allotment.
You can apply for Bio Medica Laboratories IPO through: (1) ASBA (Application Supported by Blocked Amount) via your bank's net banking or mobile app, (2) UPI-based application through your broker's app (Zerodha, Groww, Angel One, etc.), or (3) directly via your demat account. The amount is blocked in your account and deducted only upon allotment. Applications were accepted from May 21 to May 25, 2026.
The grey market premium (GMP) reflects unofficial pre-listing trading sentiment. For the latest Bio Medica Laboratories IPO GMP data, check the IPORise GMP page. Note: GMP is unofficial, speculative, and not a guaranteed indicator of listing price. Use it only as a sentiment signal alongside official subscription data.
New to reading subscription numbers? Read our guide on IPO subscription explained.
Subscription Opens Done
May 21, 2026Subscription Closes Done
May 25, 2026Basis of Allotment Done
May 26, 2026Listing on NSE Done
May 29, 2026Better odds than heavily subscribed IPOs.
Share Subscription Card
Download a branded image to share on WhatsApp, Twitter, or Telegram
Higher subscription = lower allotment probability. Progress bars compare each category relative to the highest-subscribed category.
